Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Return on Assets: 2021-2025

Historic Return on Assets for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Sep 2025 value amounting to -0.12%.

  • Arcutis Biotherapeutics' Return on Assets rose 32.00% to -0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.12%, marking a year-over-year increase of 32.00%. This contributed to the annual value of -0.41% for FY2024, which is 26.00% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Return on Assets stood at -0.12% for Q3 2025, which was up 54.24% from -0.27% recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Return on Assets ranged from a high of -0.12% in Q3 2025 and a low of -0.94% during Q2 2023.
  • Its 3-year average for Return on Assets is -0.54%, with a median of -0.44% in 2024.
  • Per our database at Business Quant, Arcutis Biotherapeutics' Return on Assets fell by 18bps in 2023 and then spiked by 51bps in 2024.
  • Over the past 5 years, Arcutis Biotherapeutics' Return on Assets (Quarterly) stood at -0.52% in 2021, then fell by 13bps to -0.65% in 2022, then decreased by 18bps to -0.83% in 2023, then skyrocketed by 47bps to -0.36% in 2024, then skyrocketed by 32bps to -0.12% in 2025.
  • Its last three reported values are -0.12% in Q3 2025, -0.27% for Q2 2025, and -0.37% during Q1 2025.